Do hypertensive patients with average cholesterol levels benefit from atorvastatin therapy?
- PMID: 12821623
- PMCID: PMC161615
Do hypertensive patients with average cholesterol levels benefit from atorvastatin therapy?
Comment in
-
No absolutes.CMAJ. 2003 Sep 30;169(7):651; author reply 651. CMAJ. 2003. PMID: 14517120 Free PMC article. No abstract available.
Similar articles
-
What are the odds at ASCOT today?Lancet. 2003 Apr 5;361(9364):1144-5. doi: 10.1016/s0140-6736(03)12977-7. Lancet. 2003. PMID: 12686031 No abstract available.
-
No difference in plasma fibrinogen levels between CAPD patients taking atorvastatin and simvastatin.Perit Dial Int. 1999 Jan-Feb;19(1):89-91. Perit Dial Int. 1999. PMID: 10201354 No abstract available.
-
[Atorvastatin for primary prevention of cardiovascular events. ASCOT-LLA Study].Internist (Berl). 2004 Mar;45(3):355-7. doi: 10.1007/s00108-003-1129-8. Internist (Berl). 2004. PMID: 14997313 Clinical Trial. German. No abstract available.
-
Cholesterol levels and the benefit of statins in heart failure.Hellenic J Cardiol. 2005 May-Jun;46(3):226-31. Hellenic J Cardiol. 2005. PMID: 15981559 Review. No abstract available.
-
Is atorvastatin superior to other statins? Analysis of the clinical trials with atorvastatin having cardiovascular endpoints.Rev Recent Clin Trials. 2006 May;1(2):143-53. doi: 10.2174/157488706776876508. Rev Recent Clin Trials. 2006. PMID: 18473965 Review.
Cited by
-
No absolutes.CMAJ. 2003 Sep 30;169(7):651; author reply 651. CMAJ. 2003. PMID: 14517120 Free PMC article. No abstract available.
References
-
- Athyros VG, Papageorgiou AA, Mercouris BR, Athyrou VV, Symeonidis AN, Basayannis EO, et al. Treatment with atorvastatin to the National Cholesterol Educational Program goal versus ‘usual’ care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study. Curr Med Res Opin 2002;18(4):220-8. - PubMed
-
- Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002;360:7-22. - PubMed
-
- Knatterud GL, Rosenberg Y, Campeau L, Geller NL, Hunninghake DB, Forman SA, et al. Long-term effects on clinical outcomes of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation in the post coronary artery bypass graft trial. Post CABG Investigators. Circulation 2000; 102 (2): 157-65. - PubMed
-
- Yusuf S, Reddy S, Ounpuu S, Anand S. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 2001;104(23):2855-64. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical